TY - JOUR
T1 - Colistin resistance in multidrug-resistant klebsiella pneumoniae strains at a perinatal maternal institute in Lima, Peru, 2015-2018
AU - Naomi-Matsuoka, Andrea
AU - Vargas, Marina
AU - Ymaña, Barbara
AU - Soza, Gabriela
AU - Pons, Maria J.
N1 - Publisher Copyright:
© 2020, Instituto Nacional de Salud. All rights reserved.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - The objective of this study was to evaluate the presence of colistin-and carbapenemic-resistant genes in multidrug-resistant Klebsiella pneumoniae strains isolated at the Instituto Materno Perinatal de Lima (2015-2018). Susceptibility levels were analyzed by disk diffusion and microdilution. The presence of colistin-and carbapenemic-resistant genes was determined by polymerase chain reaction (PCR) and was related to clonality. A total of 36 K. pneumoniae strains were analyzed, 5 (13.8%) were resistant to colistin and belonged to different clonal groups. Only 2 strains were found with carbapenemases (blaKPC and blaNDM), and no colistin plasmid genes were detected. High resistance levels to the other tested antimicrobials were observed, except for amikacin (13.9%). The results highlight the presence of colistinresistant strains (33.3% in 2018), a worrying situation as they are part of the latest treatment alternatives for infections caused by multiresistant pathogens.
AB - The objective of this study was to evaluate the presence of colistin-and carbapenemic-resistant genes in multidrug-resistant Klebsiella pneumoniae strains isolated at the Instituto Materno Perinatal de Lima (2015-2018). Susceptibility levels were analyzed by disk diffusion and microdilution. The presence of colistin-and carbapenemic-resistant genes was determined by polymerase chain reaction (PCR) and was related to clonality. A total of 36 K. pneumoniae strains were analyzed, 5 (13.8%) were resistant to colistin and belonged to different clonal groups. Only 2 strains were found with carbapenemases (blaKPC and blaNDM), and no colistin plasmid genes were detected. High resistance levels to the other tested antimicrobials were observed, except for amikacin (13.9%). The results highlight the presence of colistinresistant strains (33.3% in 2018), a worrying situation as they are part of the latest treatment alternatives for infections caused by multiresistant pathogens.
KW - Antimicrobial Drug Resistance
KW - Beta-Lactams (Source: MeSH NLM)
KW - Colistin
KW - Klebsiella pneumoniae
UR - http://www.scopus.com/inward/record.url?scp=85100879667&partnerID=8YFLogxK
U2 - 10.17843/rpmesp.2020.374.5422
DO - 10.17843/rpmesp.2020.374.5422
M3 - Artículo
C2 - 33566913
AN - SCOPUS:85100879667
SN - 1726-4634
VL - 37
SP - 716
EP - 720
JO - Revista Peruana de Medicina Experimental y Salud Publica
JF - Revista Peruana de Medicina Experimental y Salud Publica
IS - 4
ER -